FI850275A0 - Nya 6-susbtituerade furo-(3,4-c) -pyridinderivat. - Google Patents

Nya 6-susbtituerade furo-(3,4-c) -pyridinderivat.

Info

Publication number
FI850275A0
FI850275A0 FI850275A FI850275A FI850275A0 FI 850275 A0 FI850275 A0 FI 850275A0 FI 850275 A FI850275 A FI 850275A FI 850275 A FI850275 A FI 850275A FI 850275 A0 FI850275 A0 FI 850275A0
Authority
FI
Finland
Prior art keywords
susbtituerade
pyridinderivat
nya
furo
susbtituerade furo
Prior art date
Application number
FI850275A
Other languages
English (en)
Other versions
FI82051C (fi
FI82051B (fi
FI850275L (fi
Inventor
Andre Esanu
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of FI850275A0 publication Critical patent/FI850275A0/fi
Publication of FI850275L publication Critical patent/FI850275L/fi
Application granted granted Critical
Publication of FI82051B publication Critical patent/FI82051B/fi
Publication of FI82051C publication Critical patent/FI82051C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
FI850275A 1984-02-02 1985-01-22 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 6-substituerade furo-(3,4-c)-pyrinderivat. FI82051C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848402740A GB8402740D0 (en) 1984-02-02 1984-02-02 Furo-(3 4-c)-pyridine derivatives
GB8402740 1984-02-02

Publications (4)

Publication Number Publication Date
FI850275A0 true FI850275A0 (fi) 1985-01-22
FI850275L FI850275L (fi) 1985-08-03
FI82051B FI82051B (fi) 1990-09-28
FI82051C FI82051C (fi) 1991-01-10

Family

ID=10555953

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850275A FI82051C (fi) 1984-02-02 1985-01-22 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 6-substituerade furo-(3,4-c)-pyrinderivat.

Country Status (24)

Country Link
US (1) US4581362A (fi)
JP (1) JPS60181088A (fi)
AT (1) AT391700B (fi)
BE (1) BE901545A (fi)
CA (1) CA1300148C (fi)
CH (1) CH663023A5 (fi)
DE (1) DE3503435A1 (fi)
DK (1) DK158951C (fi)
DZ (1) DZ743A1 (fi)
ES (1) ES8607308A1 (fi)
FI (1) FI82051C (fi)
FR (2) FR2559152B1 (fi)
GB (1) GB8402740D0 (fi)
HK (1) HK92587A (fi)
IE (1) IE58229B1 (fi)
IT (1) IT1200587B (fi)
LU (1) LU85744A1 (fi)
MA (1) MA20342A1 (fi)
NL (1) NL8500241A (fi)
NO (1) NO160369C (fi)
OA (1) OA07947A (fi)
PT (1) PT79913B (fi)
SE (2) SE460903B (fi)
ZA (1) ZA85508B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
JPH054664A (ja) * 1991-06-21 1993-01-14 Yoozuri:Kk 運搬等用の包装体及び包装方法
WO2013102145A1 (en) 2011-12-28 2013-07-04 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
HUE035069T2 (en) 2011-12-28 2018-05-02 Global Blood Therapeutics Inc Substituted benzaldehyde compounds and their use to increase tissue oxygenation
CA2903022C (en) 2013-03-15 2021-11-09 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
KR20150132146A (ko) 2013-03-15 2015-11-25 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
PE20161035A1 (es) 2013-03-15 2016-11-13 Global Blood Therapeutics Inc Compuestos y usos de estos para la modulacion de la hemoglobina
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
JP6809681B2 (ja) 2014-02-07 2021-01-06 グローバル ブラッド セラピューティクス インコーポレイテッド ２−ヒドロキシ−６−（（２−（１−イソプロピル−１ｈ−ピラゾール−５−イル）ピリジン−３−イル）メトキシ）ベンズアルデヒドの遊離塩基の結晶多形
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
TW201731509A (zh) 2015-12-04 2017-09-16 全球血液治療公司 針對２-羥基-６-（（２-（１-異丙基-１ｈ-吡唑-５-基）吡啶-３-基）甲氧基）-苯甲醛之劑量方案
TWI663160B (zh) 2016-05-12 2019-06-21 全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3860975B1 (en) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
IN156817B (fi) * 1981-02-10 1985-11-09 Scras
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives

Also Published As

Publication number Publication date
HK92587A (en) 1987-12-11
DK45585A (da) 1985-08-03
CH663023A5 (fr) 1987-11-13
OA07947A (fr) 1987-01-31
PT79913A (en) 1985-03-01
SE8500460D0 (sv) 1985-02-01
NO850399L (no) 1985-08-05
DK45585D0 (da) 1985-02-01
IT8519327A0 (it) 1985-02-01
MA20342A1 (fr) 1985-10-01
GB8402740D0 (en) 1984-03-07
DK158951C (da) 1990-12-31
JPH0240069B2 (fi) 1990-09-10
FR2559152A1 (fr) 1985-08-09
SE460903B (sv) 1989-12-04
PT79913B (en) 1986-11-10
DZ743A1 (fr) 2004-09-13
NO160369C (no) 1989-04-12
ATA27585A (de) 1990-05-15
FI82051C (fi) 1991-01-10
ZA85508B (en) 1985-11-27
LU85744A1 (fr) 1985-07-24
SE8500460L (sv) 1985-08-03
FI82051B (fi) 1990-09-28
DE3503435A1 (de) 1985-08-08
NL8500241A (nl) 1985-09-02
IE850241L (en) 1985-08-02
FR2559062B1 (fr) 1987-05-22
FR2559062A1 (fr) 1985-08-09
ES540080A0 (es) 1986-05-16
DE3503435C2 (fi) 1991-11-07
IT1200587B (it) 1989-01-27
US4581362A (en) 1986-04-08
AT391700B (de) 1990-11-12
FR2559152B1 (fr) 1987-05-22
ES8607308A1 (es) 1986-05-16
FI850275L (fi) 1985-08-03
CA1300148C (en) 1992-05-05
BE901545A (fr) 1985-07-22
JPS60181088A (ja) 1985-09-14
DK158951B (da) 1990-08-06
IE58229B1 (en) 1993-08-11
NO160369B (no) 1989-01-02

Similar Documents

Publication Publication Date Title
FI853193L (fi) Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat.
FI850275A0 (fi) Nya 6-susbtituerade furo-(3,4-c) -pyridinderivat.
FI841273A0 (fi) Foerfarande foer frmastaellning av nya furo-(3,4-c)- pyridinderivater.
FI844279A0 (fi) Foerfarande foer framstaellning av nya 6-vinyl-furo-(3,4-c)-pyridinderivat.
FI852694A0 (fi) Nya isoindolinyl-alkyl-piperaziner.
FI850130A0 (fi) Nya 8 -asylaminoergoliner.
MX21592A (es) 1,3-oxazolidin-2-ona.
IT8521944A0 (it) 1,4-diidropiridine-2-sostituite.
FI853181L (fi) Nya 6-substituerade mitomycinderivat.
FI854180A0 (fi) Foerfarande foer framstaellning av nya 6-fenetylaminoalkyl-furo-(3,4-c)-pyridinderivat.
FI850994A0 (fi) Foerfarande foer framstaellning av nya 1,2,4-triazacykloalkadienderivat.
FI853421L (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/ hept-2-enderivat.
FI861950A0 (fi) 1,3-dioxan-etrar.
FI863300A0 (fi) 7-oxo-4-tia-1-azabicyclo/3,2,0/ hept-2-enderivat.
FI853288L (fi) Foerfarande foer framstaellning av nya 6-aminometyl-furo-(3,4-c)-pyridinderivat.
FI865158A (fi) 1-h-pyrido/3,2//1,4/-tiaziner.
FI853287A0 (fi) Nytt foerfarande foer framstaellning av 6-substituerad-furo-(3,4-c)-pyridinderivat.
FI850995L (fi) Foerfarande foer framstaellning av nya 3-merkapto-1,2,4-triazacykloalkadienderivat.
FI854026A0 (fi) 2-fenylpyrano/2,3-b/pyridiner.
IT8620495A0 (it) 2,4-dicloro-5-nitro-tiazolo.
FI853005L (fi) Nya aminoalkylpenem-foereningar.
FI841292A0 (fi) Nya timololmellanprodukter.
NO892008D0 (no) Substituert 1,2,4-oksadiazol.
NO864343D0 (no) Substituerte 1,1,2-trifenylbut-1-ener.
ATE45349T1 (de) Substituierte 2,3,4,9-tetrahydro-1h-carbazol-1essigs|urederivate.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SOCIETE DE CONSEILS DE RECHERCHES ET D APPLICATION